FDA to examine risk of vCJD from factor VIII products

12/14/2006 | Monsters and Critics

An agency advisory committee today is scheduled to examine the possibility that plasma-derived factor VIII products could transmit the fatal brain disorder variant Creutzfeldt-Jakob disease, the human version of mad cow disease. Hemophilia advocates are calling for tougher surveillance and oversight, after three people in the U.K. apparently acquired the disease from blood transfusions.

View Full Article in:

Monsters and Critics

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC